GID BIO, Inc.
Biotechnology ResearchColorado, United States2-10 Employees
GID BIO, Inc. is a small biotechnology company based in Louisville, Colorado, focused on cellular therapies for knee osteoarthritis. It is developing the SVF-2 device and related therapy, which harvests, isolates and reinserts a patient's own healing cells to address osteoarthritis pain and potentially delay or avoid total knee replacement. In pivotal clinical work, the initial study reported no serious adverse events and showed meaningful improvements in pain and function, and the U.S. FDA has granted conditional approval for a second final pivotal trial. The therapy is aimed at individuals with knee osteoarthritis and the clinicians who treat them, offering an alternative to surgery and long-term drug therapy. It addresses a substantial unmet need in a population of roughly 14 million people living with knee OA. Recent updates note ongoing pivotal-trial activities, including leadership appointments and recruitment of principal investigators across multiple trial sites.
1-888-653-2347 
support@leadiq.com 
